Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma. [electronic resource]
Producer: 20180705Description: 2475-2485 p. digitalISSN:- 1533-4406
- Administration, Oral
- Adolescent
- Adult
- Anti-Asthmatic Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Asthma -- classification
- Child
- Double-Blind Method
- Drug Therapy, Combination
- Eosinophilia -- chemically induced
- Female
- Forced Expiratory Volume -- drug effects
- Glucocorticoids -- administration & dosage
- Humans
- Injections, Subcutaneous -- adverse effects
- Intention to Treat Analysis
- Logistic Models
- Male
- Middle Aged
- Receptors, Interleukin-4 -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.